plerixafor has been researched along with Leukemia-Lymphoma, Adult T-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ainai, A; Hall, WW; Hasegawa, H; Iha, H; Kawaguchi, A; Kimura, T; Ogata, M; Okamoto, T; Orba, Y; Sata, T; Sawa, H; Tsuji, T | 1 |
1 other study(ies) available for plerixafor and Leukemia-Lymphoma, Adult T-Cell
Article | Year |
---|---|
Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice.
Topics: Adult; Aged; Animals; Anti-HIV Agents; Benzylamines; Cell Movement; Cells, Cultured; Chemokine CXCL12; Cyclams; Female; Gene Products, tax; Heterocyclic Compounds; Human T-lymphotropic virus 1; Humans; Immunoblotting; Immunoenzyme Techniques; Leukemia-Lymphoma, Adult T-Cell; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Mice, Transgenic; Middle Aged; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2009 |